Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma

David T. Fetzer; Shuchi K. Rodgers; James H. Seow; Adrian A. Dawkins; Gayatri Joshi; Helena Gabriel; Aya Kamaya

doi:10.1016/j.rcl.2019.01.004

Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma

David T. Fetzer, Shuchi K. Rodgers, James H. Seow, Adrian A. Dawkins, Gayatri Joshi, Helena Gabriel, Aya Kamaya

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

In the context of chronic liver disease (CLD), sonographic features of hepatic steatosis, cirrhosis, and portal hypertension are discussed and examples are provided. The impact of CLD and hepatocellular carcinoma (HCC) is introduced, providing the rationale for a robust HCC screening and surveillance program for at-risk patients. The American College of Radiology Liver Imaging Reporting and Data System algorithms for screening and surveillance by ultrasound and for the definitive diagnosis of HCC by contrast-enhanced ultrasound are explained, with imaging examples provided. Contrast-enhanced ultrasound technique, limitations, and pitfalls also are introduced.

Original language	English (US)
Pages (from-to)	563-583
Number of pages	21
Journal	Radiologic Clinics of North America
Volume	57
Issue number	3
DOIs	https://doi.org/10.1016/j.rcl.2019.01.004
State	Published - May 2019

Keywords

Cirrhosis
Contrast-enhanced ultrasound
HCC
LI-RADS
Screening
Surveillance
Ultrasound

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.rcl.2019.01.004

Cite this

@article{88954782340f430b81d7fe308f83bf8b,

title = "Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma",

abstract = "In the context of chronic liver disease (CLD), sonographic features of hepatic steatosis, cirrhosis, and portal hypertension are discussed and examples are provided. The impact of CLD and hepatocellular carcinoma (HCC) is introduced, providing the rationale for a robust HCC screening and surveillance program for at-risk patients. The American College of Radiology Liver Imaging Reporting and Data System algorithms for screening and surveillance by ultrasound and for the definitive diagnosis of HCC by contrast-enhanced ultrasound are explained, with imaging examples provided. Contrast-enhanced ultrasound technique, limitations, and pitfalls also are introduced.",

keywords = "Cirrhosis, Contrast-enhanced ultrasound, HCC, LI-RADS, Screening, Surveillance, Ultrasound",

author = "Fetzer, {David T.} and Rodgers, {Shuchi K.} and Seow, {James H.} and Dawkins, {Adrian A.} and Gayatri Joshi and Helena Gabriel and Aya Kamaya",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = may,

doi = "10.1016/j.rcl.2019.01.004",

language = "English (US)",

volume = "57",

pages = "563--583",

journal = "Radiologic Clinics of North America",

issn = "0033-8389",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma

AU - Fetzer, David T.

AU - Rodgers, Shuchi K.

AU - Seow, James H.

AU - Dawkins, Adrian A.

AU - Joshi, Gayatri

AU - Gabriel, Helena

AU - Kamaya, Aya

PY - 2019/5

Y1 - 2019/5

N2 - In the context of chronic liver disease (CLD), sonographic features of hepatic steatosis, cirrhosis, and portal hypertension are discussed and examples are provided. The impact of CLD and hepatocellular carcinoma (HCC) is introduced, providing the rationale for a robust HCC screening and surveillance program for at-risk patients. The American College of Radiology Liver Imaging Reporting and Data System algorithms for screening and surveillance by ultrasound and for the definitive diagnosis of HCC by contrast-enhanced ultrasound are explained, with imaging examples provided. Contrast-enhanced ultrasound technique, limitations, and pitfalls also are introduced.

AB - In the context of chronic liver disease (CLD), sonographic features of hepatic steatosis, cirrhosis, and portal hypertension are discussed and examples are provided. The impact of CLD and hepatocellular carcinoma (HCC) is introduced, providing the rationale for a robust HCC screening and surveillance program for at-risk patients. The American College of Radiology Liver Imaging Reporting and Data System algorithms for screening and surveillance by ultrasound and for the definitive diagnosis of HCC by contrast-enhanced ultrasound are explained, with imaging examples provided. Contrast-enhanced ultrasound technique, limitations, and pitfalls also are introduced.

KW - Cirrhosis

KW - Contrast-enhanced ultrasound

KW - HCC

KW - LI-RADS

KW - Screening

KW - Surveillance

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85061429918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061429918&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2019.01.004

DO - 10.1016/j.rcl.2019.01.004

M3 - Review article

C2 - 30928078

AN - SCOPUS:85061429918

SN - 0033-8389

VL - 57

SP - 563

EP - 583

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

IS - 3

ER -

Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this